Reata Pharma
(RETA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,450 | 296 | -337 | 1,358 | 680 |
| Depreciation Amortization | 1,819 | 1,548 | 1,062 | 533 | 2,510 |
| Income taxes - deferred | 17,802 | 13,427 | 9,052 | 4,724 | N/A |
| Accounts payable and accrued liabilities | 2,754 | 665 | -454 | 491 | N/A |
| Other Working Capital | -64,868 | -48,369 | -31,912 | -15,921 | -111,650 |
| Other Operating Activity | -677 | 356 | 1,372 | 79 | 19,830 |
| Operating Cash Flow | $-44,620 | $-32,077 | $-21,217 | $-8,736 | $-88,630 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -272 | -257 | -240 | -8 | -180 |
| Net Acquisitions | 12 | N/A | N/A | N/A | 40 |
| Investing Cash Flow | $-260 | $-257 | $-240 | $-8 | $-140 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -45 | -45 | -45 | -45 | N/A |
| Common Stock Issued | 39 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -864 | -328 | 15 | 15 | 1 |
| Financing Cash Flow | $-870 | $-373 | $-30 | $-30 | $1 |
| Beginning Cash Position | 87,758 | 87,758 | 87,758 | 87,758 | 176,520 |
| End Cash Position | 42,008 | 55,051 | 66,271 | 78,984 | 87,750 |
| Net Cash Flow | $-45,750 | $-32,707 | $-21,487 | $-8,774 | $-88,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,620 | -32,077 | -21,217 | -8,736 | -88,630 |
| Capital Expenditure | -272 | -257 | -240 | -8 | N/A |
| Free Cash Flow | -44,892 | -32,334 | -21,457 | -8,744 | -88,630 |